A Randomised Phase II study of Oral Vinorelbine or I.V. Vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines

A Randomised Phase II study of Oral Vinorelbine or I.V. Vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines

Hide study title
Status
Status :
Completed
Type of study
Phase II
Min. Age
60
Years old
Max. Age
-
Gender
All
Therapeutic area :
Oncology
Disease :
Metastatic breast cancer
Study medication :
Vinorelbine (NavelbineĀ® Oral)
Phase : Phase II
Start Date :
30 September 2004
End date :
01 June 2007
Study ID : PM0259 CA 221 B0
EudraCT/CTIS number : 2004-000963-81

Results

Public links :

Publication :

Send by email